MeiraGTx at the forefront of gene therapy for cancer, obesity, and vision loss
Evening Standard - 21-Dec-2023London biotech promises revolutionary therapies by replacing faulty genes & flipping gene switches
Join the club for FREE to access the whole archive and other member benefits.
President and Chief Executive Officer of MeiraGTx
Alexandria Forbes is the President, Chief Executive Officer and a member of MeiraGTx. Prior to joining MeiraGTx, Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, healthcare investor at Sivik Global Healthcare, and at Meadowvale Asset Management.
Forbes was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center. She was a research fellow at Duke University, and also at the Carnegie Institute at Johns Hopkins University. Forbes received an M.A. in Natural Sciences from Cambridge University and a Ph.D. in Molecular Genetics from Oxford University.
Visit website: https://meiragtx.com/company/our-team/
See also: MeiraGTx - Gene therapy company focusing on the eye, salivary gland, and central nervous system disorders
Details last updated 24-Dec-2023
London biotech promises revolutionary therapies by replacing faulty genes & flipping gene switches